Physician profile
Bruce Platt
NPI 1083611610
$1,955.19
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,303 · 2020: $486 · 2021: $141 · 2022: $25.43.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,096.77 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $343.16 | 2019-2020 | |
| Glaxosmithkline, LLC. | $110.17 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $73.75 | 2019 | |
| Amgen INC. | $70.40 | 2019 | |
| Astellas Pharma US INC | $39.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $35.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.03 | 2019 | |
| Amarin Pharma, INC. | $29.27 | 2019 | |
| Pfizer INC. | $24.04 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.80 | 2019 | |
| Boston Scientific Corporation | $16.51 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.45 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.72 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.27 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $12.21 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $11.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Platt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.